Publications

New arrangements for migalastat (Galafold®) – information for prescribers

This fact sheet is for current prescribers (treating physicians) with patients requiring treatment for Fabry disease. It explains how a treatment for this condition, migalastat (Galafold®), will be transitioning from the Life Saving Drugs Program to the PBS.

Downloads

New arrangements for migalastat (Galafold®) – information for prescribers

We aim to provide documents in an accessible format. If you're having problems using a document with your accessibility tools, please contact us for help.

Publication date:
Date last updated:
Publication type:
Fact sheet
Language:
English
Tags: 

Help us improve health.gov.au

If you would like a response please use the enquiries form instead.